{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:22:27Z","timestamp":1793467347928,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.atherosclerosis.2016.08.037","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T02:12:22Z","timestamp":1472609542000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia"],"prefix":"10.1016","volume":"253","author":[{"given":"Thomas","family":"Grenkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Kassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"W\u00fchle-Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Salewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Rosada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Zemojtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Hopfenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Isermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3648-2657","authenticated-orcid":false,"given":"Katrin","family":"Borucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Heigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-7275","authenticated-orcid":false,"given":"Marcus E.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priska","family":"Binner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.08.037_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A\u00a0century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2016.08.037_bib2","first-page":"22","article-title":"Clinical utility gene card for: hyperlipoproteinemia, TYPE II","author":"Kassner","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"45","key":"10.1016\/j.atherosclerosis.2016.08.037_bib3","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"issue":"36","key":"10.1016\/j.atherosclerosis.2016.08.037_bib4","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.08.037_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ejhg.2015.100","article-title":"Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction","volume":"24","author":"Braenne","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2016.08.037_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/1753-0407.12064","article-title":"Proprotein convertases subtilisin\/kexin type 9, an enzyme turned escort protein: hepatic and extra hepatic functions","volume":"5","author":"Mbikay","year":"2013","journal-title":"J.\u00a0Diabetes"},{"issue":"9874","key":"10.1016\/j.atherosclerosis.2016.08.037_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.08.037_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.08.037_bib9","first-page":"337","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2016.08.037_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2010.213975","article-title":"Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies","volume":"97","author":"Nherera","year":"2011","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.08.037_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2013.09.019","article-title":"Familial hypercholesterolaemia: a pressing issue for European health care","volume":"231","author":"Brice","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.08.037_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOL.0000000000000173","article-title":"Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia","volume":"26","author":"Pears","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.08.037_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.9218","article-title":"Molecular characterization of familial hypercholesterolemia in German and Greek patients","volume":"23","author":"Dedoussis","year":"2004","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.08.037_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<257::AID-HUMU14>3.0.CO;2-D","article-title":"Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226","volume":"13","author":"Ebhardt","year":"1999","journal-title":"Online. Hum. Mutat."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.08.037_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.1171","article-title":"Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia","volume":"18","author":"Nauck","year":"2001","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.08.037_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1023\/A:1026704517598","article-title":"Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia","volume":"23","author":"Weiss","year":"2000","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.08.037_bib17","series-title":"Who\u2014Human Genetics DoNDP. Familial Hypercholesterolaemia\u2014Report of a Second WHO Consultation","author":"Ed. Geneva: WHO","year":"1998"},{"key":"10.1016\/j.atherosclerosis.2016.08.037_bib18","first-page":"12","article-title":"Lipid lowering efficacy of atorvastatin","author":"Adams","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.atherosclerosis.2016.08.037_bib19","first-page":"12","article-title":"Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation","volume":"21","author":"Ara","year":"2008","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.08.037_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2013.10.022","article-title":"Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: results of the GRAVITY randomized study","volume":"232","author":"Ballantyne","year":"2014","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2016.08.037_bib21","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.08.037_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0149-2918(01)80001-1","article-title":"Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis","volume":"23","author":"Ballantyne","year":"2001","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.08.037_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjcard.2006.10.022","article-title":"Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)","volume":"99","author":"Ballantyne","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.08.037_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/VHRM.S49840","article-title":"Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy","volume":"9","author":"Foody","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.08.037_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"7404","key":"10.1016\/j.atherosclerosis.2016.08.037_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2016.08.037_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A\u00a0method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2016.08.037_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.08.037_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2016.08.037_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.08.037_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2016.08.037_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199805283382203","article-title":"Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease","volume":"338","author":"Tybjaerg-Hansen","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2016.08.037_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.ejhg.5201079","article-title":"Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population","volume":"11","author":"Real","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.08.037_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/humu.20256","article-title":"Update of the molecular basis of familial hypercholesterolemia in The Netherlands","volume":"26","author":"Fouchier","year":"2005","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.08.037_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.08.037_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.08.037_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.08.037_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016312989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016312989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T18:25:47Z","timestamp":1536431147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016312989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"alternative-id":["S0021915016312989"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.08.037","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}